Atrosentan makes a return visit to NephJC, but now it goes beyond changes in proteinuria and shows improved kidney outcomes. Is it enough to overcome the fluid complications?
Background, summary
This week, we will discuss the AHA/ACC 2025 hypertension guideline update. Wow, have eight years flown by?
Background
This week, we will discuss the ACHIEVE trial. Will spironolactone achieve CV benefits in ESRD?
Background
The summer book club started in 2015, with one of the best books we have done in book club, Atul Gawande's Being Mortal. I think it should be required reading for all physicians. So now, in 2025, it is the NephJC Summer Book’s tenth anniversary (which represents our eleventh book). The history has been rich:
